BONE MARROW OSTEOPONTIN AS A PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME

被引:0
|
作者
Kim, S. [1 ]
Ji, Y. S. [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ,2 ]
Kim, K. H. [3 ]
Kim, H. J. [1 ,2 ]
Lee, S. C. [2 ]
Bae, S. B. [2 ]
Kim, C. K. [1 ]
Lee, N. S. [3 ]
Lee, K. T. [2 ]
Park, S. K. [1 ]
Won, J. H. [3 ]
Hong, D. S. [1 ]
机构
[1] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Bucheon, South Korea
[2] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Cheonan, South Korea
[3] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1828
引用
收藏
页码:723 / 723
页数:1
相关论文
共 50 条
  • [41] Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome
    W Leung
    N Pitts
    K Burnette
    JM Cunningham
    EM Horwitz
    E Benaim
    G Hale
    P Woodard
    C-H Pui
    LC Bowman
    Bone Marrow Transplantation, 2001, 27 : 717 - 722
  • [42] Pyoderma Gangrenosum with Myelodysplastic Syndrome Treated with Analogous Bone Marrow Transplantation
    Yamanaka, Kazuhoshi
    Kuniyuki, Shuichi
    Maekawa, Naoki
    Yoshida, Yuki
    Teshima, Hirohumi
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (01) : 105 - 106
  • [43] Activation of Monocyte-Derived Cells in the Bone Marrow of Myelodysplastic Syndrome
    Ru, Yongxin
    Dong, Shuxu
    Zhang, Huamei
    Zhao, Shixuan
    Ru, Kun
    Zheng, Guoguang
    Xiao, Zhijie
    Eyden, Brian
    ULTRASTRUCTURAL PATHOLOGY, 2014, 38 (04) : 256 - 260
  • [44] Acquired erythropoietic uroporphyria and myelodysplastic syndrome cured by bone marrow transplantation
    de Verneuil, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 256 - 257
  • [45] Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia
    Matsushima, T
    Handa, H
    Yokohama, A
    Nagasaki, J
    Koiso, H
    Kin, Y
    Tanaka, Y
    Sakura, T
    Tsukamoto, N
    Karasawa, M
    Itoh, K
    Hirabayashi, H
    Sawamura, M
    Shinonome, S
    Shimano, S
    Miyawaki, S
    Nojima, Y
    Murakami, H
    BLOOD, 2003, 101 (09) : 3386 - 3390
  • [46] Quantitative evaluation of apoptosis in myelodysplastic syndrome using bone marrow smears
    Arimura, K
    Arima, N
    Hidaka, S
    Fujiwara, H
    Matsushita, K
    Ohtsubo, H
    Miyashita, H
    Kukita, T
    Yamaguchi, K
    Tanaka, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 243 - 243
  • [47] Association between Chiari malformation and bone marrow failure/myelodysplastic syndrome
    Akiyama, Kosuke
    Koh, Katsuyoshi
    Mori, Makiko
    Sekinaka, Yujin
    Seki, Masafumi
    Arakawa, Yuki
    Hayashi, Mayumi
    Kato, Motohiro
    Oguma, Eiji
    Nishimoto, Hiroshi
    Hanada, Ryoji
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 411 - 412
  • [48] Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome
    Campos, Paula de Melo
    Traina, Fabiola
    Santos Duarte, Adriana da Silva
    Lorand-Metze, Irene
    Costa, Fernando F.
    Saad, Sara T. O.
    LEUKEMIA RESEARCH, 2007, 31 (06) : 853 - 857
  • [49] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR 93 PATIENTS WITH MYELODYSPLASTIC SYNDROME
    ANDERSON, JE
    APPELBAUM, FR
    FISHER, LD
    SCHOCH, G
    SHULMAN, H
    ANASETTI, C
    BENSINGER, WI
    BRYANT, E
    BUCKNER, CD
    DONEY, K
    MARTIN, PJ
    SANDERS, JE
    SULLIVAN, KM
    THOMAS, ED
    WITHERSPOON, RP
    HANSEN, JA
    STORB, R
    BLOOD, 1993, 82 (02) : 677 - 681
  • [50] Bone tissue and bone marrow failure (aplastic anaemia (AA)) and hypoplastic myelodysplastic syndrome
    Ponomarenko, VM
    Rugal, VI
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 873 - 873